HRP20090281T1 - 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases - Google Patents
1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseasesInfo
- Publication number
- HRP20090281T1 HRP20090281T1 HR20090281T HRP20090281T HRP20090281T1 HR P20090281 T1 HRP20090281 T1 HR P20090281T1 HR 20090281 T HR20090281 T HR 20090281T HR P20090281 T HRP20090281 T HR P20090281T HR P20090281 T1 HRP20090281 T1 HR P20090281T1
- Authority
- HR
- Croatia
- Prior art keywords
- tetrasubstituted
- indole
- treatment
- respiratory diseases
- respiratory
- Prior art date
Links
- -1 1,2,3,4-tetrasubstituted indole Chemical class 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301569A SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Novel compounds |
SE0302305A SE0302305D0 (sv) | 2003-05-27 | 2003-08-27 | Novel Compounds |
PCT/SE2004/000808 WO2004106302A1 (en) | 2003-05-27 | 2004-05-25 | Novel substituted 3-sulfur indoles |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20090281T1 true HRP20090281T1 (en) | 2009-06-30 |
Family
ID=33492578
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20090281T HRP20090281T1 (en) | 2003-05-27 | 2009-05-15 | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
HR20110359T HRP20110359T1 (hr) | 2003-05-27 | 2011-05-16 | Upotreba derivata 3-feniltio-1h-indol-1-octene kiseline kao modulatora crth2 receptorske aktivnosti |
HRP20120390TT HRP20120390T1 (hr) | 2003-05-27 | 2012-05-10 | Intermedijarni spoj etil estera 4-(acetilamino)-3-[(4-klorofenil)tio]-2-metil-1h-indol-1-octene kiseline |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20110359T HRP20110359T1 (hr) | 2003-05-27 | 2011-05-16 | Upotreba derivata 3-feniltio-1h-indol-1-octene kiseline kao modulatora crth2 receptorske aktivnosti |
HRP20120390TT HRP20120390T1 (hr) | 2003-05-27 | 2012-05-10 | Intermedijarni spoj etil estera 4-(acetilamino)-3-[(4-klorofenil)tio]-2-metil-1h-indol-1-octene kiseline |
Country Status (31)
Country | Link |
---|---|
US (4) | US7687535B2 (is) |
EP (3) | EP1656346B1 (is) |
JP (2) | JP4541361B2 (is) |
KR (3) | KR101067586B1 (is) |
CN (2) | CN102391171A (is) |
AR (1) | AR044552A1 (is) |
AT (3) | ATE425965T1 (is) |
AU (1) | AU2004242624B2 (is) |
BR (1) | BRPI0410711B8 (is) |
CA (1) | CA2526866C (is) |
CO (1) | CO5630030A2 (is) |
CY (3) | CY1109104T1 (is) |
DE (2) | DE602004020072D1 (is) |
DK (3) | DK2281815T3 (is) |
ES (3) | ES2361485T3 (is) |
HK (3) | HK1090635A1 (is) |
HR (3) | HRP20090281T1 (is) |
IL (4) | IL171928A (is) |
IS (2) | IS2722B (is) |
MX (1) | MXPA05012680A (is) |
MY (1) | MY144483A (is) |
NO (1) | NO20056130L (is) |
NZ (1) | NZ543722A (is) |
PL (3) | PL2281815T3 (is) |
PT (3) | PT2281815E (is) |
RU (1) | RU2361860C2 (is) |
SE (2) | SE0301569D0 (is) |
SI (3) | SI2025670T1 (is) |
TW (2) | TW201024261A (is) |
WO (1) | WO2004106302A1 (is) |
ZA (1) | ZA200509598B (is) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
SE0202241D0 (sv) | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
SE0301569D0 (sv) * | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
SE0303180D0 (sv) * | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
JP4051398B2 (ja) | 2004-03-11 | 2008-02-20 | アクテリオン ファマシューティカルズ リミテッド | テトラヒドロピリドインドール誘導体 |
JP5137240B2 (ja) | 2004-12-27 | 2013-02-06 | アクテリオン ファーマシューティカルズ リミテッド | Crth2受容体アンタゴニストとしての2,3,4,9−テトラヒドロ−1h−カルバゾール誘導体 |
GB0500604D0 (en) * | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
DOP2006000016A (es) * | 2005-01-26 | 2006-07-31 | Aventis Pharma Inc | 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2. |
CA2601979C (en) | 2005-04-21 | 2014-06-17 | Laboratoires Serono S.A. | 2,3 substituted pyrazine sulfonamides |
US8236963B2 (en) | 2005-05-24 | 2012-08-07 | Merck Serono Sa | Tricyclic spiro derivatives as CRTH2 modulators |
US7842692B2 (en) | 2005-07-22 | 2010-11-30 | Shionogi & Co., Ltd. | Azaindole derivative having PGD2 receptor antagonistic activity |
WO2007010964A1 (ja) | 2005-07-22 | 2007-01-25 | Shionogi & Co., Ltd. | Pgd2受容体アンタゴニスト活性を有するインドール誘導体 |
EP2407453A1 (en) | 2005-09-27 | 2012-01-18 | Shionogi & Co., Ltd. | PGD2 receptor antagonist |
ES2399061T3 (es) * | 2005-09-30 | 2013-03-25 | Pulmagen Therapeutics (Asthma) Limited | Quinolinas y su uso terapéutico |
CN102558021A (zh) * | 2006-05-26 | 2012-07-11 | 阿斯利康(瑞典)有限公司 | 联芳基或芳基-杂芳基取代的吲哚类化合物 |
ES2618352T3 (es) | 2006-06-16 | 2017-06-21 | The Trustees Of The University Of Pennsylvania | Antagonistas del receptor de prostaglandina D2 para el tratamiento de la alopecia androgenética |
KR20090042808A (ko) * | 2006-07-22 | 2009-04-30 | 옥사겐 리미티드 | 씨알티에이치2 길항제 활성을 갖는 화합물 |
RU2448092C2 (ru) | 2006-08-07 | 2012-04-20 | Актелион Фармасьютиклз Лтд | Производные (3-амино-1,2,3,4-тетрагидро-9н-карбазол-9-ил)уксусной кислоты |
GB0702456D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | New combination |
NZ581856A (en) * | 2007-06-21 | 2011-05-27 | Actimis Pharmaceuticals Inc | Amine salts of the CRTH2 antagonist {4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)benzyl)pyrimidin-5-yl} acetic acid |
BRPI0813436A2 (pt) * | 2007-06-21 | 2014-12-23 | Actimis Pharmaceuticals Inc | Particulados de ácido (4,6-bis (dimetilamino)-2-(4-(4-(trifluorometil) benzamido)-benzil)pirimindin-5-il} acético, composição farmacêutica, métodos para o tratamento, prevenção ou melhora de um ou mais sintomas de uma doença mediada por crth2, de uma doença relacionada com eosinófilo, de uma doença relacionada com basófilo, e de uma doença inflamatória, e, processo para a preparação dos particulados. |
AU2008337342B2 (en) | 2007-12-14 | 2012-05-24 | Pulmagen Therapeutics (Asthma) Limited | Indoles and their therapeutic use |
US7750027B2 (en) | 2008-01-18 | 2010-07-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
US20110312945A1 (en) * | 2008-10-01 | 2011-12-22 | James Jia | Crth2 modulators |
AU2010212970A1 (en) | 2009-02-12 | 2011-08-18 | Merck Serono S.A. | Phenoxy acetic acid derivatives |
JP5675800B2 (ja) * | 2009-07-06 | 2015-02-25 | アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag | 4−(アセチルアミノ))−3−[(4−クロロ−フェニル)チオ]−2−メチル−1h−インドール−1−酢酸の製造のための中間体および方法 |
GB0913345D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | New combination 802 |
WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
US9032565B2 (en) | 2009-12-16 | 2015-05-19 | Kohler Co. | Touchless faucet assembly and method of operation |
WO2011073662A1 (en) | 2009-12-17 | 2011-06-23 | Astrazeneca Ab | Combination of a benzoxazinone and a further agent for treating respiratory diseases |
AR080703A1 (es) | 2010-03-22 | 2012-05-02 | Actelion Pharmaceuticals Ltd | Derivados de 3-(heteroaril-amino)-1,2,3,4-tetrahidro-9h-carbazol, moduladores de receptores de prostaglandina d2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos alergicos o inmunitarios tales como asma. |
GB201021979D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | New compound |
GB201021992D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | Compound |
EP2697223B1 (en) | 2011-04-14 | 2016-07-13 | Actelion Pharmaceuticals Ltd. | 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators |
BR112014014558A8 (pt) | 2011-12-16 | 2017-07-04 | Atopix Therapeutics Ltd | composição farmacêutica, uso de um antagonista de crth2 e de um inibidor de bomba de prótons, e, kit para o tratamento de esofagite eosinofílica |
CN108938441A (zh) | 2012-03-21 | 2018-12-07 | 宾夕法尼亚大学理事会 | 用于调节毛发生长的组合物和方法 |
WO2014055595A1 (en) * | 2012-10-05 | 2014-04-10 | Merck Sharp & Dohme Corp. | Indoline compounds as aldosterone synthase inhibitiors related applications |
US20140303121A1 (en) | 2013-03-15 | 2014-10-09 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
SI2970265T1 (sl) * | 2013-03-15 | 2018-10-30 | Plexxikon Inc. | Heterociklične spojine in njihova uporaba |
WO2014190199A1 (en) * | 2013-05-24 | 2014-11-27 | The California Institute For Biomedical Research | Compounds for treatment of drug resistant and persistent tuberculosis |
PL3119779T3 (pl) | 2014-03-17 | 2019-01-31 | Idorsia Pharmaceuticals Ltd | Pochodne kwasu azaindolooctowego i ich zastosowanie jako modulatorów receptora prostaglandyny d2 |
RU2016140708A (ru) | 2014-03-18 | 2018-04-18 | Идорсиа Фармасьютиклз Лтд | Производные азаиндол уксусной кислоты и их применение в качестве модуляторов рецептора простагландина d2 |
GB201407807D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
GB201407820D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
CA2993972A1 (en) | 2015-07-30 | 2017-02-02 | The Trustees Of The University Of Pennsylvania | Single nucleotide polymorphic alleles of human dp-2 gene for detection of susceptibility to hair growth inhibition by pgd2 |
KR20180053345A (ko) | 2015-09-15 | 2018-05-21 | 이도르시아 파마슈티컬스 리미티드 | 결정질 형태 |
WO2019075243A1 (en) | 2017-10-13 | 2019-04-18 | Plexxikon Inc. | SOLID FORMS OF A COMPOUND FOR MODULATING KINASES |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE790679A (fr) | 1971-11-03 | 1973-04-27 | Ici Ltd | Derives de l'indole |
JPH0615542B2 (ja) | 1986-07-22 | 1994-03-02 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
US5095031A (en) | 1990-08-20 | 1992-03-10 | Abbott Laboratories | Indole derivatives which inhibit leukotriene biosynthesis |
WO1993005020A1 (en) | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
FR2692574B1 (fr) | 1992-06-23 | 1995-06-23 | Sanofi Elf | Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles. |
PL175788B1 (pl) | 1993-02-24 | 1999-02-26 | Merck & Co Inc | Amidowe pochodne indolu i zawierające je kompozycje farmaceutyczne |
US5486525A (en) * | 1993-12-16 | 1996-01-23 | Abbott Laboratories | Platelet activating factor antagonists: imidazopyridine indoles |
US5567711A (en) | 1995-04-19 | 1996-10-22 | Abbott Laboratories | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
SK285141B6 (sk) | 1996-02-13 | 2006-07-07 | Astrazeneca Uk Limited | Použitie chinazolínového derivátu, chinazolínový derivát, spôsob jeho prípravy a farmaceutická kompozícia, ktorá ho obsahuje |
KR100489174B1 (ko) | 1996-03-05 | 2005-09-30 | 제네카-파마 소시에떼아노님 | 4-아닐리노퀴나졸린유도체 |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
TW472045B (en) | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
AR017256A1 (es) | 1997-08-21 | 2001-09-05 | American Home Prod | Compuestos de indol sustituidos, metodo para la sintesis en fase solida de los mismos, conjuntos de combinacion para ser empleados en dicho metodo, uso delos compuestos para preparar un medicamento y composiciones farmaceuticas que los comprenden |
WO1999032112A1 (en) | 1997-12-19 | 1999-07-01 | Eli Lilly And Company | Method for treating diabetes |
US6916841B2 (en) | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
AU5886500A (en) | 1999-06-23 | 2001-01-09 | Sepracor, Inc. | Indolyl-benzimidazole antibacterials, and methods of use thereof |
WO2001032621A1 (fr) | 1999-10-29 | 2001-05-10 | Wakunaga Pharmaceutical Co., Ltd. | Nouveaux derives d'indole, et medicaments contenant lesdits derives comme principe actif |
DZ3377A1 (fr) | 1999-12-24 | 2001-07-05 | Aventis Pharma Ltd | Azaindoles |
WO2001092224A1 (en) | 2000-05-31 | 2001-12-06 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
CA2411160A1 (en) | 2000-07-07 | 2002-01-17 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as vascular damaging agents |
US6878522B2 (en) * | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
MXPA02012903A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como inhibidores de angiogenesis. |
JP4595182B2 (ja) * | 2000-09-07 | 2010-12-08 | ソニー株式会社 | 情報記録装置、情報再生装置、情報記録方法、情報再生方法、および情報記録媒体、並びにプログラム提供媒体 |
TWI317634B (en) | 2001-12-13 | 2009-12-01 | Nat Health Research Institutes | Aroyl indoles compounds |
JP4209332B2 (ja) | 2002-02-01 | 2009-01-14 | エフ.ホフマン−ラ ロシュ アーゲー | α−1アゴニストとしての置換インドール |
SE0200356D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
SE0200411D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
EP2423190A1 (en) | 2002-05-16 | 2012-02-29 | Shionogi&Co., Ltd. | Compounds Exhibiting PGD 2 Receptor Antagonism |
SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
SE0202241D0 (sv) | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
SE0202463D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | Novel compounds |
SE0301569D0 (sv) * | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
RU2006109108A (ru) | 2003-10-14 | 2007-11-20 | Оксаген Лимитед (GB) | Соединения, обладающие активностью антагонистов crth2 рецепторов |
SE0303180D0 (sv) | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
GB0500604D0 (en) | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
GB2422831A (en) | 2005-02-04 | 2006-08-09 | Oxagen Ltd | Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor |
CN102558021A (zh) | 2006-05-26 | 2012-07-11 | 阿斯利康(瑞典)有限公司 | 联芳基或芳基-杂芳基取代的吲哚类化合物 |
MX2008015501A (es) | 2006-06-08 | 2009-02-18 | Neurokey As | Uso de agonistas del receptor de canabinoide como farmacos inductores de hipotermia para el tratamiento de isquemia. |
JP5237938B2 (ja) | 2006-06-28 | 2013-07-17 | サノフイ | 新規なcxcr2阻害剤 |
-
2003
- 2003-05-27 SE SE0301569A patent/SE0301569D0/xx unknown
- 2003-08-27 SE SE0302305A patent/SE0302305D0/xx unknown
-
2004
- 2004-05-19 TW TW099109193A patent/TW201024261A/zh unknown
- 2004-05-19 TW TW093114113A patent/TWI328004B/zh not_active IP Right Cessation
- 2004-05-24 AR ARP040101792A patent/AR044552A1/es unknown
- 2004-05-25 DK DK10180348.4T patent/DK2281815T3/da active
- 2004-05-25 PT PT10180348T patent/PT2281815E/pt unknown
- 2004-05-25 MX MXPA05012680A patent/MXPA05012680A/es active IP Right Grant
- 2004-05-25 SI SI200431669T patent/SI2025670T1/sl unknown
- 2004-05-25 PL PL10180348T patent/PL2281815T3/pl unknown
- 2004-05-25 AT AT04734774T patent/ATE425965T1/de active
- 2004-05-25 PL PL08165755T patent/PL2025670T3/pl unknown
- 2004-05-25 PL PL04734774T patent/PL1656346T3/pl unknown
- 2004-05-25 DE DE602004020072T patent/DE602004020072D1/de not_active Expired - Lifetime
- 2004-05-25 AU AU2004242624A patent/AU2004242624B2/en not_active Ceased
- 2004-05-25 CN CN2011102633202A patent/CN102391171A/zh active Pending
- 2004-05-25 DK DK04734774T patent/DK1656346T3/da active
- 2004-05-25 SI SI200431874T patent/SI2281815T1/sl unknown
- 2004-05-25 PT PT08165755T patent/PT2025670E/pt unknown
- 2004-05-25 AT AT08165755T patent/ATE502010T1/de active
- 2004-05-25 KR KR1020057022513A patent/KR101067586B1/ko active IP Right Grant
- 2004-05-25 ES ES08165755T patent/ES2361485T3/es not_active Expired - Lifetime
- 2004-05-25 WO PCT/SE2004/000808 patent/WO2004106302A1/en active Application Filing
- 2004-05-25 KR KR1020117009788A patent/KR101067535B1/ko not_active IP Right Cessation
- 2004-05-25 SI SI200431120T patent/SI1656346T1/sl unknown
- 2004-05-25 US US10/558,228 patent/US7687535B2/en active Active
- 2004-05-25 PT PT04734774T patent/PT1656346E/pt unknown
- 2004-05-25 EP EP04734774A patent/EP1656346B1/en not_active Expired - Lifetime
- 2004-05-25 RU RU2005137403/04A patent/RU2361860C2/ru active
- 2004-05-25 JP JP2006532212A patent/JP4541361B2/ja not_active Expired - Fee Related
- 2004-05-25 EP EP10180348A patent/EP2281815B1/en not_active Expired - Lifetime
- 2004-05-25 DE DE602004031894T patent/DE602004031894D1/de not_active Expired - Lifetime
- 2004-05-25 BR BRPI0410711A patent/BRPI0410711B8/pt not_active IP Right Cessation
- 2004-05-25 DK DK08165755.3T patent/DK2025670T3/da active
- 2004-05-25 ES ES04734774T patent/ES2322650T3/es not_active Expired - Lifetime
- 2004-05-25 ES ES10180348T patent/ES2382606T3/es not_active Expired - Lifetime
- 2004-05-25 KR KR1020117009790A patent/KR20110050754A/ko not_active Application Discontinuation
- 2004-05-25 MY MYPI20041992A patent/MY144483A/en unknown
- 2004-05-25 CN CN2004800146027A patent/CN1795174B/zh not_active Expired - Fee Related
- 2004-05-25 AT AT10180348T patent/ATE552243T1/de active
- 2004-05-25 EP EP08165755A patent/EP2025670B1/en not_active Expired - Lifetime
- 2004-05-25 NZ NZ543722A patent/NZ543722A/xx not_active IP Right Cessation
- 2004-05-25 CA CA2526866A patent/CA2526866C/en not_active Expired - Fee Related
-
2005
- 2005-11-14 IL IL171928A patent/IL171928A/en not_active IP Right Cessation
- 2005-11-23 CO CO05118882A patent/CO5630030A2/es active IP Right Grant
- 2005-11-28 ZA ZA200509598A patent/ZA200509598B/en unknown
- 2005-12-20 IS IS8189A patent/IS2722B/is unknown
- 2005-12-22 NO NO20056130A patent/NO20056130L/no not_active Application Discontinuation
-
2006
- 2006-10-11 HK HK06111158.9A patent/HK1090635A1/xx not_active IP Right Cessation
-
2008
- 2008-10-23 IL IL194872A patent/IL194872A0/en unknown
-
2009
- 2009-03-04 US US12/397,618 patent/US20090163518A1/en not_active Abandoned
- 2009-05-15 HR HR20090281T patent/HRP20090281T1/xx unknown
- 2009-05-28 CY CY20091100564T patent/CY1109104T1/el unknown
- 2009-06-30 HK HK09105852.7A patent/HK1126773A1/xx not_active IP Right Cessation
- 2009-06-30 HK HK11107570.0A patent/HK1149563A1/xx not_active IP Right Cessation
-
2010
- 2010-03-31 JP JP2010082748A patent/JP2010155862A/ja active Pending
- 2010-08-09 IS IS8920A patent/IS8920A/is unknown
-
2011
- 2011-03-14 US US13/047,280 patent/US20110263614A1/en not_active Abandoned
- 2011-04-11 IL IL212265A patent/IL212265A0/en unknown
- 2011-04-14 IL IL212371A patent/IL212371A0/en unknown
- 2011-05-16 HR HR20110359T patent/HRP20110359T1/hr unknown
- 2011-05-16 CY CY20111100464T patent/CY1111469T1/el unknown
-
2012
- 2012-01-05 US US13/344,051 patent/US20120178764A1/en not_active Abandoned
- 2012-05-10 HR HRP20120390TT patent/HRP20120390T1/hr unknown
- 2012-05-29 CY CY20121100486T patent/CY1112853T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20090281T1 (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
RS52625B (en) | FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES | |
ATE440603T1 (de) | 8-hydroxychinolinderivate | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
ME01992B (me) | Jedinjenje diarilhidantoina | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
HRP20060254A2 (en) | Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases | |
PT1379520E (pt) | Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b | |
ATE302775T1 (de) | Carbolinderivate | |
RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
RS50140B (sr) | Postupak za dobijanje perkihinina i njegova upotreba | |
DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
ATE346067T1 (de) | Carbolinderivate | |
EA200701181A1 (ru) | Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний | |
NO20052908D0 (no) | Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
ES2187261B2 (es) | Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos. | |
PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
NO20040881L (no) | Orale antidiabetes midler. | |
DK1641454T3 (da) | Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere | |
NO20051282L (no) | Antitumorale analoger av lamellariner. | |
NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
DE602005007765D1 (de) | Neue indol- oder benzimidazol-derivate | |
DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
DK1204658T3 (da) | Benzofurylpiperazin-serotoninagonister | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides |